Study guide
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols
Key Takeaways Explain This Topic AI
Rapid sequence induction (RSI) is indicated for patients at high risk of pulmonary aspiration, including full stomach, acute trauma, bowel obstruction, acute peritonitis, symptomatic GERD, gastroparesis, and pregnancy ≥14 weeks gestation.
Denitrogenation with 100% O₂ expands the functional residual capacity (FRC) oxygen reservoir from ~450 mL to >2000 mL, granting 6-8 minutes of safe apnea in healthy adults; protocols include 3 minutes of tidal breathing or 8 deep vital capacity breaths in 60 seconds (EtO₂ ≥ 0.90).
Cricoid pressure (Sellick maneuver) compresses the upper esophagus against the C6 vertebra with 10 N awake and 30 N upon loss of consciousness; pressure MUST be immediately released if active vomiting occurs to prevent esophageal rupture.
Neuromuscular blockade for RSI requires rapid-onset agents: Succinylcholine at 1.0-1.5 mg/kg IV (onset 30-60s) or high-dose Rocuronium at 1.0-1.2 mg/kg IV (onset 60s, reversibility with Sugammadex 16 mg/kg).
Verification of tracheal intubation requires continuous quantitative waveform capnography demonstrating ≥3-5 consecutive respiratory cycles with persistent plateau; direct cord visualization and auscultation serve as essential secondary confirmations.
Last updated: August 2026
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols
Rapid sequence induction (RSI) is a specialized airway management technique engineered to achieve rapid endotracheal intubation while minimizing the critical time interval between loss of protective airway reflexes and inflation of the endotracheal tube (ETT) cuff. Mastery of aspiration risk stratification, preoxygenation physiology, cricoid force dynamics, pharmacologic timing, and verification standards is vital for safe CRNA practice.
1. Pulmonary Aspiration Pathophysiology & Clinical Indications for RSI
Pulmonary aspiration of gastric contents remains a leading contributor to anesthesia-related morbidity and mortality. When acidic gastric contents enter the tracheobronchial tree, they trigger an acute chemical pneumonitis known historically as Mendelson's Syndrome . +-------------------------------------------------------------------------+
- | MENDELSON'S SYNDROME CLASSICAL CRITERIA |
- +------------------------------------+------------------------------------+
- | Critical Gastric Fluid Volume | Critical Gastric Fluid pH |
- +------------------------------------+------------------------------------+
- | • Gastric volume > 0.4 mL/kg | • Gastric pH < 2.5 |
- | (or > 25 mL in a 70 kg adult) | • Severe chemical burn of alveolar-|
- | • Particulate matter worsens | capillary membranes leading to |
- | atelectasis and inflammatory | intense bronchospasm, exudation, |
- | exudative response | and severe hypoxemia |
- +------------------------------------+------------------------------------+
- Clinical Indications & Aspiration Risk Factors
Any condition that delays gastric emptying, increases intragastric pressure, or impairs the competence of the lower esophageal sphincter (LES) warrants an RSI protocol: +-------------------------------------------------------------------------+
- | CLINICAL RISK FACTORS REQUIRING RSI |
- +-----------------------+-------------------------------------------------+
- | Clinical Category | Pathophysiologic Mechanism |
- +-----------------------+-------------------------------------------------+
- | **Non-Fasted State** | Solid intake < 6-8 hours or clear liquids < 2 |
- | | hours; residual solid and acidic liquid volume |
- | **Emergency Surgery / | Pain, anxiety, and sympathetic activation halt |
- | Acute Trauma** | normal gastric motility immediately upon injury |
- | **Gastrointestinal | Mechanical obstruction, paralytic ileus, active |
- | Pathology** | peritonitis, acute appendicitis, bowel ischemia |
- | **Symptomatic GERD / | Incompetent lower esophageal sphincter, loss of |
- | Hiatal Hernia** | normal anatomical barrier at gastroesophageal jn|
- | **Pregnancy (≥14 wk)**| Progesterone reduces LES tone; gravid uterus |
- | | mechanically elevates intragastric pressure |
- | **Gastroparesis** | Autonomic neuropathy (diabetes mellitus), chronic|
- | | uremia, systemic sclerosis, Parkinson's disease |
- | **Opioid Use** | Profound inhibition of gastric emptying and |
- | | coordinated gastrointestinal peristalsis |
- | **Morbid Obesity** | Elevated baseline intra-abdominal pressure and |
- | | increased incidence of hiatal hernia/GERD |
- | **Elevated ICP** | Brain injury disrupting central vagal control |
- +-----------------------+-------------------------------------------------+
- 2. Preoxygenation & Denitrogenation Kinetics
Preoxygenation (denitrogenation) replaces the nitrogen residing in the patient's Functional Residual Capacity (FRC) with pure oxygen, creating an intrapulmonary oxygen reservoir that sustains cellular respiration during apnea.
The FRC Oxygen Reservoir
In a standard 70 kg 70 \text{ kg} 70 kg adult breathing room air ( 21 % O 2 21\% \text{ O}_2 21% O 2 ):
F R C ≈ 30 mL/kg ≈ 2100 − 2500 mL FRC \approx 30 \text{ mL/kg} \approx 2100 - 2500 \text{ mL} FRC ≈ 30 mL/kg ≈ 2100 − 2500 mL
At 21 % O 2 21\% \text{ O}_2 21% O 2 , total FRC oxygen content is only ≈ 450 mL \approx 450 \text{ mL} ≈ 450 mL .
Basal metabolic oxygen consumption ( V O 2 VO_2 V O 2 ) is ≈ 3.5 mL/kg/min ≈ 250 mL/min \approx 3.5 \text{ mL/kg/min} \approx 250 \text{ mL/min} ≈ 3.5 mL/kg/min ≈ 250 mL/min .
Without denitrogenation, arterial desaturation ( S p O 2 < 90 % SpO_2 < 90\% Sp O 2 < 90% ) occurs within 1.5 − 2 minutes 1.5 - 2 \text{ minutes} 1.5 − 2 minutes of apnea.
Following maximal denitrogenation with 100 % O 2 100\% \text{ O}_2 100% O 2 :
Alveolar nitrogen ( 79 % 79\% 79% ) is washed out, lifting alveolar oxygen concentration to > 90 % >90\% > 90% .
FRC oxygen reservoir expands to > 2000 − 2200 mL >2000 - 2200 \text{ mL} > 2000 − 2200 mL .
Safe apnea time (time until S p O 2 SpO_2 Sp O 2 drops below 90 % 90\% 90% ) extends to 6 − 8 minutes 6 - 8 \text{ minutes} 6 − 8 minutes in healthy adults. +-------------------------------------------------------------------------+
- | STANDARD PREOXYGENATION PROTOCOLS |
- +------------------------------------+------------------------------------+
- | 1. Tidal Volume Breathing Method | 2. Deep Vital Capacity Method |
- +------------------------------------+------------------------------------+
- | • 100% FiO₂ via tight mask seal | • 8 deep vital capacity breaths |
- | • 3 minutes of normal tidal | over 60 seconds (or 4 breaths |
- | breathing at FGF ≥ 10 L/min | over 30 seconds if emergency) |
- | • Endpoint: End-Tidal O₂ (EtO₂) | • Comparable denitrogenation to |
- | reaches ≥ 0.90 (90%) | 3-minute tidal method |
- +------------------------------------+------------------------------------+
- Clinical Factors Accelerating Desaturation
Safe apnea time is drastically shortened in populations with reduced FRC, elevated V O 2 VO_2 V O 2 , or ventilation-perfusion ( V / Q V/Q V / Q ) mismatching:
Morbid Obesity: Reduced chest wall compliance and elevated abdominal pressure compress FRC; increased metabolic mass raises V O 2 VO_2 V O 2 (safe apnea drops to < 2.5 − 3 minutes <2.5-3 \text{ minutes} < 2.5 − 3 minutes ). Use ramped positioning (head elevated above clavicles) to expand FRC.
Pregnancy (3rd Trimester): Elevated diaphragm shrinks FRC by 20 − 30 % 20-30\% 20 − 30% ; fetal-placental unit elevates V O 2 VO_2 V O 2 by 35 − 50 % 35-50\% 35 − 50% .
Pediatric Patients: High metabolic rate ( V O 2 ≈ 6 − 8 mL/kg/min VO_2 \approx 6-8 \text{ mL/kg/min} V O 2 ≈ 6 − 8 mL/kg/min ) and highly compliant chest wall lead to rapid desaturation within < 1 − 2 minutes <1-2 \text{ minutes} < 1 − 2 minutes .
Sepsis / Hypermetabolic States / ARDS: Extreme V O 2 VO_2 V O 2 consumption combined with intrapulmonary shunt.
Apneic Oxygenation (THRIVE / High-Flow Nasal Cannula)
Applying nasal cannula oxygen at 10 − 15 L/min 10 - 15 \text{ L/min} 10 − 15 L/min during induction and subsequent laryngoscopy generates continuous mass flow. Because alveolar oxygen uptake ( 250 mL/min 250 \text{ mL/min} 250 mL/min ) far exceeds carbon dioxide excretion into the alveoli ( 20 mL/min 20 \text{ mL/min} 20 mL/min while the remaining C O 2 CO_2 C O 2 dissolves in blood), a negative subatmospheric pressure gradient develops in the alveoli, drawing fresh oxygen passively down the tracheobronchial tree (apneic diffusion oxygenation) and substantially prolonging safe apnea.
3. Cricoid Pressure (Sellick Maneuver): Anatomy, Force & Protocols
Introduced by Brian Sellick in 1961, cricoid pressure is designed to occlude the upper esophagus and hypopharynx to prevent passive regurgitation of gastric contents into the pharynx during induction. [SELLICK MANEUVER ANATOMICAL CROSS-SECTION]
- Anterior Neck
- |
- [Thyroid Cartilage]
- |
- (Cricovocal Membrane)
- |
- >>> [CRICOID CARTILAGE] <<< (Only complete cartilaginous
- | ring; signet-ring shape)
- v
- [Upper Esophageal Lumen] (Post-cricoid hypopharynx
- | compressed shut)
- v
- [C6 VERTEBRAL BODY] (Rigid posterior bony
- counter-support)
- Application Force & Technique
Landmark Identification: Palpate the thyroid prominence, move inferiorly across the cricothyroid membrane to locate the prominent cricoid ring (located at the level of the sixth cervical vertebra, C6 ).
Applied Force Progression:
Awake / Conscious State: Apply 10 Newtons (N) 10 \text{ Newtons (N)} 10 Newtons (N) of force ( ≈ 1 kg \approx 1 \text{ kg} ≈ 1 kg or 2.2 lbs 2.2 \text{ lbs} 2.2 lbs of pressure) using the thumb and index/middle finger. This prevents patient discomfort, retching, or airway occlusion.
Loss of Consciousness (Unconscious): Increase force to 30 Newtons (N) 30 \text{ Newtons (N)} 30 Newtons (N) ( ≈ 3 kg \approx 3 \text{ kg} ≈ 3 kg or 6.7 lbs 6.7 \text{ lbs} 6.7 lbs of pressure) as the hypnotic takes effect, maintaining steady posterior pressure until endotracheal intubation is confirmed and the cuff is fully inflated. +-------------------------------------------------------------------------+
- | SELLICK vs BURP MANEUVER DISTINCTION |
- +------------------------------------+------------------------------------+
- | Sellick Maneuver (Cricoid Pressure)| BURP Maneuver |
- +------------------------------------+------------------------------------+
- | • Target: Cricoid Cartilage (C6) | • Target: Thyroid Cartilage |
- | • Direction: Purely Posterior | • Direction: Backward, Upward, |
- | • Purpose: Esophageal occlusion | Rightward, Pressure |
- | to prevent passive regurgitation | • Purpose: Improves glottic visual |
- | • Maintained until ETT cuff up | alignment during laryngoscopy |
- +------------------------------------+------------------------------------+
- Critical Safety Rules & Contraindications
Active Vomiting (ABSOLUTE RELEASE MANDATE): If the patient begins active vomiting or retching, cricoid pressure MUST BE RELEASED IMMEDIATELY . Active retching against an occluded upper esophagus generates immense intragastric and intraluminal pressure, risking catastrophic esophageal rupture (Boerhaave's Syndrome) . Suction the oropharynx and tilt the bed into Trendelenburg.
Unstable Cervical Spine Fracture: Cricoid pressure can displace unstable vertebral fractures at C6.
Direct Laryngeal / Cricotracheal Trauma: Risk of complete airway collapse.
Impaired Laryngoscopic Visualization: If cricoid pressure distorts laryngeal anatomy or impedes tube passage, it should be adjusted, relaxed, or released.
4. RSI Pharmacologic Agents & Dosing Strategies
Classic RSI avoids positive-pressure bag-mask ventilation prior to intubation to prevent introducing air into the stomach (which reduces LES pressure and provokes regurgitation). In a "modified RSI", gentle bag-mask ventilation with peak inspiratory pressures < 15 − 20 cmH 2 O <15 - 20 \text{ cmH}_2\text{O} < 15 − 20 cmH 2 O may be utilized if the patient desaturates rapidly or cannot tolerate apnea. +-------------------------------------------------------------------------+
- | RSI PHARMACOTHERAPY COMPARISON |
- +--------------------+------------------------+---------------------------+
- | Drug & Class | RSI Dosage | Key Clinical Highlights |
- +--------------------+------------------------+---------------------------+
- | **Propofol** | 1.5 - 2.5 mg/kg IV | Rapid onset (30-40s); |
- | (Hypnotic) | | profound vasodilation; |
- | | | suppresses airway reflexes|
- | **Etomidate** | 0.2 - 0.3 mg/kg IV | Hemodynamic stability; |
- | (Hypnotic) | | transient adrenal cortical|
- | | | suppression; myoclonus |
- | **Ketamine** | 1.5 - 2.0 mg/kg IV | Sympathetic stimulation; |
- | (Hypnotic/NMDA) | | bronchodilation; ideal for|
- | | | shock, trauma, & asthma |
- | **Succinylcholine**| 1.0 - 1.5 mg/kg IV | Gold standard NMBA onset |
- | (Depolarizing NMBA)| | (30-60s); duration 5-10m; |
- | | | hyperkalemia risk |
- | **Rocuronium** | 1.0 - 1.2 mg/kg IV | High-dose onset (60s); |
- | (Non-depolarizing) | (Standard is 0.6) | duration 60-90m; reverse |
- | | | with Sugammadex 16 mg/kg |
- +--------------------+------------------------+---------------------------+
- Succinylcholine vs. High-Dose Rocuronium in RSI
Succinylcholine ( 1.0 − 1.5 mg/kg 1.0 - 1.5 \text{ mg/kg} 1.0 − 1.5 mg/kg IV):
Provides complete vocal cord paralysis within 30 − 60 seconds 30 - 60 \text{ seconds} 30 − 60 seconds with rapid spontaneous recovery in 5 − 10 minutes 5 - 10 \text{ minutes} 5 − 10 minutes .
Absolute Contraindications: Malignant Hyperthermia susceptibility, hyperkalemia ( K + > 5.5 mEq/L K^+ > 5.5 \text{ mEq/L} K + > 5.5 mEq/L ), denervation injuries (spinal cord injury, stroke > 24 − 48 hours >24-48 \text{ hours} > 24 − 48 hours old), severe burn injury ( > 24 − 48 hours >24-48 \text{ hours} > 24 − 48 hours old), muscular dystrophies (Duchenne/Becker), severe intra-abdominal sepsis ( > 24 hours >24 \text{ hours} > 24 hours old), and plasma cholinesterase (pseudocholinesterase) deficiency.
Rocuronium ( 1.0 − 1.2 mg/kg 1.0 - 1.2 \text{ mg/kg} 1.0 − 1.2 mg/kg IV):
Administering twice the standard intubating dose ( 2 × E D 95 = 0.6 mg/kg → 1.0 − 1.2 mg/kg 2 \times ED_{95} = 0.6 \text{ mg/kg} \rightarrow 1.0 - 1.2 \text{ mg/kg} 2 × E D 95 = 0.6 mg/kg → 1.0 − 1.2 mg/kg ) accelerates onset to ≈ 60 seconds \approx 60 \text{ seconds} ≈ 60 seconds , achieving intubating conditions comparable to succinylcholine.
Duration Caveat: Neuromuscular blockade lasts 60 − 90 minutes 60 - 90 \text{ minutes} 60 − 90 minutes .
Immediate Rescue Reversal: In a "cannot intubate, cannot ventilate" scenario following high-dose rocuronium, Sugammadex 16 mg/kg 16 \text{ mg/kg} 16 mg/kg IV provides rapid encapsulation and full reversal within 2 − 3 minutes 2 - 3 \text{ minutes} 2 − 3 minutes , outperforming spontaneous recovery from succinylcholine.
5. Tracheal Intubation Verification & Troubleshooting Protocols
Proper confirmation of endotracheal tube placement is mandatory immediately following intubation to prevent unheralded esophageal intubation and catastrophic hypoxic brain injury. +-------------------------------------------------------------------------+
- | INTUBATION CONFIRMATION STANDARDS |
- +------------------------------------+------------------------------------+
- | Primary / Gold Standard Monitor | Secondary Clinical Assessments |
- +------------------------------------+------------------------------------+
- | • **Continuous Quantitative | • Direct visualization of ETT cuff |
- | Waveform Capnography** | passing through vocal cords |
- | • Demonstration of ≥ 3 to 5 | • Bilateral equal chest expansion |
- | consecutive breaths with normal | • Bilateral equal breath sounds in |
- | alveolar plateau and stable | mid-axillary and apical fields |
- | ETCO₂ amplitude (>30 mmHg) | • Absence of gastric gurgling |
- | • Sustained, repeatable waveforms | • Condensation/fogging in tube |
- +------------------------------------+------------------------------------+
- Capnographic Esophageal Intubation Recognition
When an ETT is erroneously placed into the esophagus:
Ingestion of carbonated beverages or prior bag-mask ventilation may force residual C O 2 CO_2 C O 2 gas into the stomach.
The capnograph may display 1 − 2 1 - 2 1 − 2 small, irregular, rapidly attenuating C O 2 CO_2 C O 2 waves.
By breath 3 − 5 3 - 5 3 − 5 , the measured C O 2 CO_2 C O 2 exponentially decays to zero (flatline).
Rule: Failure to sustain ≥ 5 \ge 5 ≥ 5 consistent, rectangular capnogram waveforms mandates immediate ETT removal and re-oxygenation via mask. [CAPNOGRAM WAVEFORM DECAY PATTERNS]
- Tracheal Placement (Sustained Waves) Esophageal Placement (Rapid Decay)
- CO₂ (mmHg) CO₂ (mmHg)
- 40 | /-----\ /-----\ /-----\ 40 | /--\
- 20 | / \/ \/ \ 20 | / \ /\
- 0 +----------------------------> 0 +--------\/---\__________->
- Breath 1 Breath 2 Breath 3 Breath 1 2 3 4 (Flatline)